首页> 外文期刊>Annals of Surgery >Challenges in surgical management of abdominal pain in the neutropenic cancer patient.
【24h】

Challenges in surgical management of abdominal pain in the neutropenic cancer patient.

机译:中性粒细胞减少症患者腹部疼痛的外科治疗中的挑战。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Abdominal pain in neutropenic cancer patients presents a unique clinical challenge for surgeons. The purposes of this retrospective study were to characterize the clinicopathologic factors associated with the presentation of neutropenia and abdominal pain, examine the treatment strategies used, and define associated outcomes for these patients. METHODS: We identified patients with concomitant neutropenia (absolute neutrophil count <1000 cells/microL) and abdominal pain who had been evaluated by surgical oncologists over a period of more than 6 years. A Cox proportional hazards regression model was used to analyze the association between clinicopathologic factors and overall survival time. RESULTS: Sixty patients were included in this analysis. After our clinical and radiographic evaluations, we determined that the most frequent causes of the abdominal pain were neutropenic enterocolitis (28%) and small bowel obstruction (12%); the cause remained uncertain in 35%. Surgical interventions had been performed in 9 patients. The 30- and 90-day mortality rates for all patients were 30% and 52%, respectively. Multivariate analysis revealed that severe sepsis, a relatively long duration of neutropenia, and the lack of surgical intervention were significant adverse prognostic factors for overall survival. CONCLUSIONS: Abdominal pain as a symptom in neutropenic patients continues to be a diagnostic and therapeutic challenge and is associated with a high mortality rate. Based on our results, we conclude that efforts should focus on improving neutrophil counts and on treating the frequent and serious comorbidities found in these patients. Surgery should be delayed, when possible, to allow for neutrophil recovery.
机译:背景:中性粒细胞减少症患者的腹部疼痛对外科医生提出了独特的临床挑战。这项回顾性研究的目的是表征与中性粒细胞减少和腹痛的表现相关的临床病理因素,检查所使用的治疗策略,并确定这些患者的相关结局。方法:我们确定了伴有中性粒细胞减少症(中性粒细胞绝对计数<1000个细胞/微升)并伴有腹痛的患者,这些患者经外科肿瘤学家评估超过6年。使用Cox比例风险回归模型分析临床病理因素与总生存时间之间的关联。结果:该分析纳入了60例患者。经过临床和影像学评估,我们确定最常见的腹痛原因是中性粒细胞减少性小肠结肠炎(28%)和小肠梗阻(12%);原因仍然不确定,占35%。 9例患者进行了手术干预。所有患者的30天和90天死亡率分别为30%和52%。多因素分析表明,严重的败血症,中性粒细胞减少症的持续时间相对较长以及缺乏手术干预是整体生存的重要不良预后因素。结论:中性粒细胞减少症患者的腹痛是一种症状,仍然是诊断和治疗上的挑战,并伴有较高的死亡率。根据我们的结果,我们得出的结论是,努力应集中在改善嗜中性白血球数量和治疗这些患者中常见和严重的合并症。如有可能,应延迟手术以恢复中性粒细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号